Vistim Labs Inc. — Form D/A
Vistim Labs Inc. of Claymont, DE, a company, filed a Form D amendment with the SEC on 2023-03-21. The offering totals $800K, of which $550K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-21
- Form: D/A
- Accession: 0001960015-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $550K
- Remaining: $250K
- Investors: 3
- Date of first sale: 2022-12-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469519
Issuer
- Name: Vistim Labs Inc.
- CIK: 0001960015
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2093 Philadelphia Pike #3690, Claymont, DE, 19703
- Phone: (203) 940-3751
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Frank Zanow | Director | Claymont, DE |
| James Hamet | Director | Claymont, DE |
| James Hamet | Executive Officer | Claymont, DE |
Other filings by this issuer (4)
More